410 ILCS 417/ Reducing Cervical Cancer and Saving Lives Act.

Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.

410 ILCS 417/1

(410 ILCS 417/1)

Sec. 1. Short title. This Act may be cited as the Reducing Cervical Cancer and Saving Lives Act.

(Source: P.A. 102-1018, eff. 1-1-23.)

410 ILCS 417/5

(410 ILCS 417/5)

Sec. 5. Applicability.

This Act applies to a hospital, outpatient department, clinic, mobile unit, or other entity that provides cervical cancer screening services in the State of Illinois.

(Source: P.A. 102-1018, eff. 1-1-23.)

410 ILCS 417/10

(410 ILCS 417/10)

Sec. 10. Definitions. As used in this Act:

"Cervical cancer screening service" means an examination and laboratory test for the screening and detection of cervical cancer, including conventional Pap smear screening, liquid-based cytology, or human papillomavirus (HPV) detection methods.

"Department" means the Department of Public Health.

(Source: P.A. 102-1018, eff. 1-1-23.)

410 ILCS 417/15

(410 ILCS 417/15)

Sec. 15. Cervical cancer screening services; written report.

(a) A hospital, outpatient department, clinic, mobile unit, or other entity that provides a cervical cancer screening service shall prepare a written report of the results of any cervical cancer screening service provided to a patient.     The written report shall be provided to the patient's referring health care professional. If a patient's referring health care professional is not available or if there is no such referring health care professional, only the summary of the written report under subsection (b) is required.

(b) A summary of the written report of the results of any cervical cancer screening service shall be sent directly to the patient in terms easily understood by a lay person.  The summary of the written report may be provided electronically if the patient has consented to receive electronic communications.  The summary of the written report shall advise the patient to consult with the patient's health care professional to discuss the results of the cervical cancer screening.

(c) The Department, in collaboration with experts in cervical cancer and cervical cancer screening, shall develop suggested cervical cancer screening reporting language, in terms easily understood by a lay person, to be sent to patients with the summary of the written report required under subsection (b).

(d)  This Section does not create a duty of care or other legal obligation beyond the duty to provide a written report as set forth in this Section.

(e) This Section is operative beginning 6 months after the Department makes the suggested cervical cancer screening reporting language required under subsection (c) publicly
     available, including by posting the suggested cervical cancer screening reporting language on the Department's website.

(Source: P.A. 102-1018, eff. 1-1-23.)

410 ILCS 417/20

(410 ILCS 417/20)

    (Section scheduled to be repealed on June 30, 2027)
    Sec. 20. Human papillomavirus (HPV) vaccine services pilot program.

(a) The Department shall establish a pilot program to provide for the administration of human papillomavirus (HPV) vaccines to persons enrolled in the Department's Illinois Breast and Cervical Cancer Program who are:

(1) 26 years of age or younger, have not received the

full HPV vaccine series, and would like to receive the vaccine series; or

(2) 26 years of age or older, have not completed the

HPV vaccine series, and whose clinicians recommend the HPV vaccine series.

    (b) The pilot program shall be implemented no later than July 1, 2024.
    (c) Any lead agency of the Illinois Breast and Cervical Cancer Program may participate in the pilot program.

(d) This Section is repealed on June 30, 2027.

(Source: P.A. 102-1018, eff. 1-1-23.)

410 ILCS 417/50

(410 ILCS 417/50)

Sec. 50. (Amendatory provisions; text omitted).

(Source: P.A. 102-1018, eff. 1-1-23; text omitted.)